(Q43041544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Edwin T Parlevliet

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Judith E de Leeuw van Weenen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Johannes A Romijn

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

8 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

E318-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20530733%20AND%20SRC:MED&resulttype=core&format=json

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Role of leptin in the regulation of glucagon-like peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Neuropeptide Y in normal eating and in genetic and dietary-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

The level of NPY receptor mRNA expression in diet-induced obese and resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Targeting the CNS to treat type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Diet-induced type II diabetes in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00191.2010